Disagree
Home Swiss Remedies Swiss Remedies
Ondansetron 2 AMPULES
Ondansetron 2 AMPULES - Swiss Remedies

Ondansetron 2 AMPULES - Swiss Remedies

Brand:
Category:
Substance:
Dosage:
2 mg/ml
Package:
10 ml
Price:
0
See options
Product Overview

Ondansetron is a potent inhibitor of 5-HT3 receptors, effectively mitigating nausea and vomiting but also showing a profound influence on cardiac physiology. Research reveals that ondansetron blocks small-conductance Ca2+-activated K+ (SK) channels, pivotal in cardiac repolarization, particularly under reduced repolarization reserve. Its ability to inhibit SK currents at therapeutic levels highlights its promise in managing arrhythmias caused by excessive SK activity. However, its association with drug-induced long QT syndrome (diLQTS) raises concerns about its role in prolonging cardiac repolarization. Studies show ondansetron inhibits both native and genetically altered SK channels, including KCNN2 variants, contributing to QT prolongation in predisposed patients. Observations in murine hearts and human cell models validate its dual effects, reinforcing the need for judicious use in patients with genetic or cardiac vulnerabilities.

References:

Ko, J.-S., Guo, S., Hassel, J., Celestino-Soper, P., Lynnes, T.C., Tisdale, J.E., Zheng, J.J., Taylor, S.E., Foroud, T., Murray, M.D., Kovacs, R.J., Li, X., Lin, S.-F., Chen, Z., Vatta, M., Chen, P.-S. and Rubart, M., 2018. Ondansetron and its effects on IKAS and long QT syndrome. American Journal of Physiology - Heart and Circulatory Physiology.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Ondansetron 2 AMPULES by Swiss Remedies, consult with your doctor or healthcare professional.

Explore More Products
FAQ
Does ondansetron affect patients with genetic mutations?
Yes, studies show that patients with mutations in genes like KCNN2, which increase SK current activity, may be more susceptible to QT prolongation when taking ondansetron.
References:

Ko, J.-S., Guo, S., Hassel, J., Celestino-Soper, P., Lynnes, T.C., Tisdale, J.E., Zheng, J.J., Taylor, S.E., Foroud, T., Murray, M.D., Kovacs, R.J., Li, X., Lin, S.-F., Chen, Z., Vatta, M., Chen, P.-S. and Rubart, M., 2018. Ondansetron and its effects on IKAS and long QT syndrome. American Journal of Physiology - Heart and Circulatory Physiology.

What are SK channels, and why are they important?
Small-conductance Ca2+-activated K+ (SK) channels are crucial for cardiac repolarization, maintaining the heart’s electrical stability. Inhibition of these channels by ondansetron can influence arrhythmic risk.
References:

Ko, J.-S., Guo, S., Hassel, J., Celestino-Soper, P., Lynnes, T.C., Tisdale, J.E., Zheng, J.J., Taylor, S.E., Foroud, T., Murray, M.D., Kovacs, R.J., Li, X., Lin, S.-F., Chen, Z., Vatta, M., Chen, P.-S. and Rubart, M., 2018. Ondansetron and its effects on IKAS and long QT syndrome. American Journal of Physiology - Heart and Circulatory Physiology.

Are there benefits of ondansetron’s SK channel inhibition?
Ondansetron's ability to block SK currents may help control arrhythmias caused by excessive SK channel activity, though further research is needed to establish its therapeutic role in this area.
References:

Ko, J.-S., Guo, S., Hassel, J., Celestino-Soper, P., Lynnes, T.C., Tisdale, J.E., Zheng, J.J., Taylor, S.E., Foroud, T., Murray, M.D., Kovacs, R.J., Li, X., Lin, S.-F., Chen, Z., Vatta, M., Chen, P.-S. and Rubart, M., 2018. Ondansetron and its effects on IKAS and long QT syndrome. American Journal of Physiology - Heart and Circulatory Physiology.